| Schedule of effects of the revision on company’s previously issued unaudited condensed consolidated financial statements for the periods indicated |
| | | | | | | | | | | General and administrative expense | | | | | | (1,003) | | | | | | | | | | | (1,003) | | | | | | | | (5,467) | | | | | | (4,464) | | | | | (5,289) | | | | | | (4,286) | | | | | (5,336) | | | | | | (4,333) | | Basic and diluted net loss per share | | | (0.50) | | | | | | (0.41) | |
| | | | | | | | | | | Additional paid-in capital | | | | | | (1,003) | | | | | | | | (29,635) | | | | | | (28,632) | | Total stockholders' equity | | | | | | | | | | |
| | Additional Paid-in Capital | | | | Total Stockholders' Equity | | | | | | | | | | | | | | | | | | | | | | Balance as of December 31, 2025 | | | | | | | | | | | | (24,299) | | | | | | (24,299) | | | | | | | | | | | Shares issued in private placement registered direct offerings | | | | | | (1,003) | | | | | | | | | | | | | | | | | | (1,003) | | | | | | | | | | | (1,003) | | | | | | | | | | | | | | | | | | (1,003) | | | | | Warrants issued to placement agent | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (2,966) | | | | | | (1,963) | | | (2,966) | | | | | | (1,963) | | Balance as of March 31, 2026 | | | | | | (1,003) | | | | | | (27,265) | | | | | | (26,262) | | | | | | | | | | | Balance as of June 30, 2026 | | | | | | (1,003) | | | | | | (29,635) | | | | | | (28,632) | | | | | | | | | | |
| | | | | | | | Cash flows from operating activities: | | | | | | | | | | |
| | | (5,336) | | | | | | (4,333) | | | | | | | | (1,003) | | | | | Net cash used in operating activities: | | | (5,873) | | | | | | (5,873) | | Non-cash financing activities: | | | | | | | | | | | Warrants issued for equity offering costs | | | | | | | | | | |
|